Fipamezole in Neurogenic Orthostatic Hypotension

Clinical trial NCT00758849 · UNKNOWN

Trial details

NCT number: NCT00758849
Sponsor: Juvantia Pharma Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's Disease Multiple System Atrophy

Start date: 2008-09-01
Primary completion: 2009-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.